NO975953L - Rekombinante adenoviruser, deres anvendelse for fremstilling av AAV'er, komplementær cellelinje samt farmasöytiske preparater inneholdende adenovirusene - Google Patents
Rekombinante adenoviruser, deres anvendelse for fremstilling av AAV'er, komplementær cellelinje samt farmasöytiske preparater inneholdende adenoviruseneInfo
- Publication number
- NO975953L NO975953L NO975953A NO975953A NO975953L NO 975953 L NO975953 L NO 975953L NO 975953 A NO975953 A NO 975953A NO 975953 A NO975953 A NO 975953A NO 975953 L NO975953 L NO 975953L
- Authority
- NO
- Norway
- Prior art keywords
- adenoviruses
- aavs
- preparation
- cell line
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9507570A FR2735789B1 (fr) | 1995-06-23 | 1995-06-23 | Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant |
PCT/FR1996/000968 WO1997000947A1 (fr) | 1995-06-23 | 1996-06-20 | Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO975953L true NO975953L (no) | 1997-12-18 |
NO975953D0 NO975953D0 (no) | 1997-12-18 |
Family
ID=9480335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975953A NO975953D0 (no) | 1995-06-23 | 1997-12-18 | Rekombinante adenoviruser, deres anvendelse for fremstilling av AAV'er, komplementær cellelinje samt farmasöytiske preparater inneholdende adenovirusene |
Country Status (16)
Country | Link |
---|---|
US (3) | US6420170B1 (es) |
EP (1) | EP0833896A1 (es) |
JP (1) | JP3821846B2 (es) |
KR (1) | KR100514070B1 (es) |
AU (1) | AU716508B2 (es) |
BR (1) | BR9608965A (es) |
CA (1) | CA2222270A1 (es) |
CZ (1) | CZ295934B6 (es) |
FR (1) | FR2735789B1 (es) |
HU (1) | HU224679B1 (es) |
IL (2) | IL122710A (es) |
MX (1) | MX9709549A (es) |
NO (1) | NO975953D0 (es) |
SK (1) | SK174297A3 (es) |
WO (1) | WO1997000947A1 (es) |
ZA (1) | ZA965306B (es) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL122614A0 (en) | 1995-06-15 | 1998-08-16 | Introgene Bv | Packaging systems for human recombinant adenovirus to be used in gene therapy |
US6265212B1 (en) | 1995-06-15 | 2001-07-24 | Introgene B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
US6783980B2 (en) | 1995-06-15 | 2004-08-31 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
FR2737222B1 (fr) * | 1995-07-24 | 1997-10-17 | Transgene Sa | Nouveaux vecteurs viraux et lignee pour la therapie genique |
US5891718A (en) * | 1996-03-27 | 1999-04-06 | Vical Incorporated | Tetracycline inducible/repressible systems |
EP0931158A1 (en) * | 1996-09-06 | 1999-07-28 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
EP0860445A1 (en) | 1997-02-18 | 1998-08-26 | Hoechst Aktiengesellschaft | New nucleotide sequences for the cell cycle regulated expression of structural genes |
EP0859008A3 (en) * | 1997-02-18 | 2000-04-05 | Hoechst Aktiengesellschaft | Nucleic acid construct for the cell cycle regulated expression of structural genes |
US6696423B1 (en) | 1997-08-29 | 2004-02-24 | Biogen, Inc. | Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
US6670188B1 (en) | 1998-04-24 | 2003-12-30 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
WO2000016799A1 (en) * | 1998-09-23 | 2000-03-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of treating chronic pain |
DE69930294T2 (de) * | 1998-10-19 | 2006-11-02 | Powderject Vaccines, Inc., Madison | Minimale promotoren und ihre verwendung |
CN1074459C (zh) * | 1998-11-25 | 2001-11-07 | 马丁 | 重组腺病毒-胸苷激酶构建体及其获得方法和用途 |
EP1083230A1 (en) * | 1999-09-10 | 2001-03-14 | Academisch Medisch Centrum Amsterdam | Viral replicons and viruses dependent on inducing agents |
US7115391B1 (en) * | 1999-10-01 | 2006-10-03 | Genovo, Inc. | Production of recombinant AAV using adenovirus comprising AAV rep/cap genes |
GB0027088D0 (en) * | 2000-11-06 | 2000-12-20 | Glaxo Group Ltd | DNA expression vectors |
JP2004536572A (ja) * | 2001-02-23 | 2004-12-09 | セル・ジェネシス・インコーポレイテッド | 新規ベクター構築物 |
KR100432953B1 (ko) * | 2001-09-01 | 2004-05-28 | 김주항 | 개선된 종양 살상 효과를 나타내는 재조합 아데노바이러스 |
US7569217B2 (en) * | 2001-09-24 | 2009-08-04 | University Of Saskatchewan | Porcine adenovirus E1 and E4 regions |
CA2369985A1 (en) * | 2002-01-18 | 2003-07-18 | Duke University | Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
KR100697245B1 (ko) * | 2005-03-28 | 2007-03-21 | 한국생명공학연구원 | 중금속 유도성 프로모터와 이의 생물공학적 활용 |
US8859256B2 (en) | 2011-10-05 | 2014-10-14 | Genelux Corporation | Method for detecting replication or colonization of a biological therapeutic |
US20140087362A1 (en) | 2012-03-16 | 2014-03-27 | Aladar A. Szalay | Methods for assessing effectiveness and monitoring oncolytic virus treatment |
US20130280170A1 (en) | 2012-04-20 | 2013-10-24 | Aladar A. Szalay | Imaging methods for oncolytic virus therapy |
US20140140959A1 (en) | 2012-10-05 | 2014-05-22 | Aladar A. Szalay | Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes |
US10238700B2 (en) | 2014-01-02 | 2019-03-26 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
DK3207130T3 (da) | 2014-10-14 | 2019-11-11 | Halozyme Inc | Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme |
JP7527758B2 (ja) | 2016-04-15 | 2024-08-05 | アルパイン イミューン サイエンシズ インコーポレイテッド | Cd80バリアント免疫調節タンパク質およびその使用 |
KR102536850B1 (ko) | 2016-04-15 | 2023-05-26 | 알파인 이뮨 사이언시즈, 인코포레이티드 | Icos 리간드 변이체 면역조절 단백질 및 그의 용도 |
US11471488B2 (en) | 2016-07-28 | 2022-10-18 | Alpine Immune Sciences, Inc. | CD155 variant immunomodulatory proteins and uses thereof |
CA3032120A1 (en) | 2016-07-28 | 2018-02-01 | Alpine Immune Sciences, Inc. | Cd155 variant immunomodulatory proteins and uses thereof |
US11834490B2 (en) | 2016-07-28 | 2023-12-05 | Alpine Immune Sciences, Inc. | CD112 variant immunomodulatory proteins and uses thereof |
UY37406A (es) | 2016-09-20 | 2018-03-23 | Boehringer Ingelheim Vetmedica Gmbh | Nuevo sitio de inserción orf70 de ehv |
TW201823467A (zh) | 2016-09-20 | 2018-07-01 | 德商百靈佳殷格翰維美迪加股份有限公司 | 犬腺病毒載體 |
KR102566066B1 (ko) | 2016-09-20 | 2023-08-16 | 베링거잉겔하임베트메디카게엠베하 | 신규한 돼지 인플루엔자 백신 |
EA201990719A1 (ru) | 2016-09-20 | 2019-10-31 | Новые промоторы | |
JP2020500010A (ja) | 2016-10-20 | 2020-01-09 | アルパイン イミューン サイエンシズ インコーポレイテッド | 分泌性バリアント免疫調節タンパク質および改変細胞療法 |
US11920156B2 (en) | 2017-02-09 | 2024-03-05 | Indapta Therapeutics, Inc. | Engineered natural killer (NK) cells and compositions and methods thereof |
US11732022B2 (en) | 2017-03-16 | 2023-08-22 | Alpine Immune Sciences, Inc. | PD-L2 variant immunomodulatory proteins and uses thereof |
EP3596114A2 (en) | 2017-03-16 | 2020-01-22 | Alpine Immune Sciences, Inc. | Cd80 variant immunomodulatory proteins and uses thereof |
EP4306537A3 (en) | 2017-03-16 | 2024-03-06 | Alpine Immune Sciences, Inc. | Pd-l1 variant immunomodulatory proteins and uses thereof |
WO2019079520A2 (en) | 2017-10-18 | 2019-04-25 | Alpine Immune Sciences, Inc. | ICOS VARIANT LIGAND IMMUNOMODULATORY IMMUNOMODULATORY PROTEINS, COMPOSITIONS AND METHODS THEREOF |
WO2019236633A2 (en) | 2018-06-04 | 2019-12-12 | Calidi Biotherapeutics, Inc. | Cell-based vehicles for potentiation of viral therapy |
US11505782B2 (en) | 2018-06-04 | 2022-11-22 | Calidi Biotherapeutics, Inc. | Cell-based vehicles for potentiation of viral therapy |
US12065476B2 (en) | 2018-06-15 | 2024-08-20 | Alpine Immune Sciences, Inc. | PD-1 variant immunomodulatory proteins and uses thereof |
US11242528B2 (en) | 2018-08-28 | 2022-02-08 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
JP7329593B2 (ja) | 2018-11-06 | 2023-08-18 | カリディ・バイオセラピューティクス・インコーポレイテッド | 細胞媒介性腫瘍溶解性ウイルス治療のための増強された系 |
JP7541516B2 (ja) | 2018-11-21 | 2024-08-28 | インダプタ セラピューティクス インコーポレイテッド | ナチュラルキラー(nk)細胞サブセットの増大のための方法ならびに関連する組成物および方法 |
CA3120868A1 (en) | 2018-11-30 | 2020-06-04 | Alpine Immune Sciences, Inc. | Cd86 variant immunomodulatory proteins and uses thereof |
US12024709B2 (en) | 2019-02-27 | 2024-07-02 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
SG11202108459QA (en) | 2019-02-27 | 2021-09-29 | Actym Therapeutics Inc | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
KR20230088306A (ko) | 2020-04-22 | 2023-06-19 | 인답타 세라뷰틱스 인코포레이티드 | 자연 살해(nk) 세포 조성물 및 이를 생성하는 방법 |
US20230203535A1 (en) * | 2020-05-26 | 2023-06-29 | St. Jude Children's Research Hospital, Inc. | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations |
WO2022147481A1 (en) | 2020-12-30 | 2022-07-07 | Ansun Biopharma Inc. | Combination therapy of an oncolytic virus delivering a foreign antigen and an engineered immune cell expressing a chimeric receptor targeting the foreign antigen |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0905253A3 (en) * | 1992-12-03 | 2000-11-02 | Genzyme Corporation | Adenoviral vector deleted of all E4-ORF except ORF6 |
FR2705686B1 (fr) * | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
US5866755A (en) * | 1993-06-14 | 1999-02-02 | Basf Aktiengellschaft | Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
US5814618A (en) * | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
FR2707664B1 (fr) * | 1993-07-13 | 1995-09-29 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
JP4190028B2 (ja) * | 1993-07-13 | 2008-12-03 | アベンテイス・フアルマ・ソシエテ・アノニム | 欠陥組換えアデノウイルスベクター及び遺伝子治療での使用 |
US6686200B1 (en) * | 1993-08-31 | 2004-02-03 | Uab Research Foundation | Methods and compositions for the large scale production of recombinant adeno-associated virus |
US5698443A (en) * | 1995-06-27 | 1997-12-16 | Calydon, Inc. | Tissue specific viral vectors |
FR2716682B1 (fr) * | 1994-01-28 | 1996-04-26 | Centre Nat Rech Scient | Procédé de préparation de virus adéno-associés (AAV) recombinants et utilisations. |
FR2716893B1 (fr) * | 1994-03-03 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, leur préparation et leur utilisation thérapeutique. |
US5639661A (en) * | 1994-03-23 | 1997-06-17 | The University Of Iowa Research Foundation | Genes and proteins for treating cystic fibrosis |
US5756283A (en) * | 1995-06-05 | 1998-05-26 | The Trustees Of The University Of Pennsylvania | Method for improved production of recombinant adeno-associated viruses for gene therapy |
US6110744A (en) * | 1996-11-13 | 2000-08-29 | Board Of Regents, The University Of Texas System | Diminishing viral gene expression by promoter replacement |
-
1995
- 1995-06-23 FR FR9507570A patent/FR2735789B1/fr not_active Expired - Fee Related
-
1996
- 1996-06-09 IL IL122710A patent/IL122710A/en unknown
- 1996-06-09 IL IL12271096A patent/IL122710A0/xx not_active IP Right Cessation
- 1996-06-20 BR BR9608965A patent/BR9608965A/pt not_active Application Discontinuation
- 1996-06-20 JP JP50363797A patent/JP3821846B2/ja not_active Expired - Fee Related
- 1996-06-20 MX MX9709549A patent/MX9709549A/es not_active IP Right Cessation
- 1996-06-20 WO PCT/FR1996/000968 patent/WO1997000947A1/fr not_active Application Discontinuation
- 1996-06-20 AU AU63639/96A patent/AU716508B2/en not_active Ceased
- 1996-06-20 HU HU9900050A patent/HU224679B1/hu not_active IP Right Cessation
- 1996-06-20 CZ CZ19974130A patent/CZ295934B6/cs not_active IP Right Cessation
- 1996-06-20 US US08/981,354 patent/US6420170B1/en not_active Expired - Fee Related
- 1996-06-20 EP EP96922971A patent/EP0833896A1/fr not_active Withdrawn
- 1996-06-20 KR KR1019970709621A patent/KR100514070B1/ko not_active IP Right Cessation
- 1996-06-20 SK SK1742-97A patent/SK174297A3/sk unknown
- 1996-06-20 CA CA002222270A patent/CA2222270A1/fr not_active Abandoned
- 1996-06-20 US US08/981,354 patent/US20020098165A1/en active Granted
- 1996-06-21 ZA ZA965306A patent/ZA965306B/xx unknown
-
1997
- 1997-12-18 NO NO975953A patent/NO975953D0/no not_active Application Discontinuation
-
2002
- 2002-04-15 US US10/121,616 patent/US7033826B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CZ413097A3 (cs) | 1998-03-18 |
JP3821846B2 (ja) | 2006-09-13 |
KR100514070B1 (ko) | 2005-12-21 |
SK174297A3 (en) | 1998-09-09 |
FR2735789B1 (fr) | 1997-07-25 |
CA2222270A1 (fr) | 1997-01-09 |
IL122710A (en) | 2006-10-05 |
MX9709549A (es) | 1998-03-31 |
FR2735789A1 (fr) | 1996-12-27 |
ZA965306B (en) | 1997-01-24 |
EP0833896A1 (fr) | 1998-04-08 |
NO975953D0 (no) | 1997-12-18 |
IL122710A0 (en) | 1998-08-16 |
HUP9900050A3 (en) | 2001-08-28 |
US6420170B1 (en) | 2002-07-16 |
AU6363996A (en) | 1997-01-22 |
AU716508B2 (en) | 2000-02-24 |
US7033826B2 (en) | 2006-04-25 |
KR19990028307A (ko) | 1999-04-15 |
CZ295934B6 (cs) | 2005-12-14 |
US20020098165A1 (en) | 2002-07-25 |
WO1997000947A1 (fr) | 1997-01-09 |
BR9608965A (pt) | 1999-06-29 |
US20030039634A1 (en) | 2003-02-27 |
JPH11507835A (ja) | 1999-07-13 |
HU224679B1 (hu) | 2005-12-28 |
HUP9900050A1 (hu) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO975953D0 (no) | Rekombinante adenoviruser, deres anvendelse for fremstilling av AAV'er, komplementær cellelinje samt farmasöytiske preparater inneholdende adenovirusene | |
IL122347A0 (en) | Recombinant adenovirus and adeno-associated virus cell lines methods of production and pharmaceutical compositions containing the same | |
GB2292080B (en) | Cosmetic formulations having keratolytic and/or anti-acne activity,their preparations and use | |
EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
NO982580L (no) | Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene | |
NO990793L (no) | 7<alfa>-(<Epsilon>-aminoalkyl)-°stratriener, fremgangsmÕte for fremstilling av disse, farmas°ytiske preparater inneholdende disse, samt deres anvendelse for fremstilling av legemidler | |
FI102132B1 (fi) | ATM-solun otsikkokenttien käyttö radiovälitteisessä ATM-tiedonsiirrossa | |
AU3171997A (en) | Cosmetic and/or pharmaceutical preparations | |
NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
NO307510B1 (no) | Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav | |
FR2694296B1 (fr) | Peptides inhibant l'activité des protéines ras, préparation et utilisation. | |
NO942910L (no) | Nye baccatin-III- og 10-desacetyl-baccatin-III-derivater, deres fremstillinger, samt farmasöytiske preparater inneholdende derivatene | |
NO20016247L (no) | Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene | |
IL113484A0 (en) | Viral proteins pharmaceutical compositions containing them their preparation and use | |
AU5650894A (en) | Tachyquinine antagonists, their preparation and use in pharmaceutical formulations | |
DK439589A (da) | Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme | |
FR2680372B1 (fr) | Preparations aqueuses stables d'enzymes et leur utilisation. | |
AU2408397A (en) | Ob protein receptor genes and use of the same | |
NO305750B1 (no) | Substituerte benzensulfonylureaer og deres anvendelse for fremstilling av farmas°ytiske preparater samt farmas°ytiske preparater inneholdende forbindelsene | |
IT9020072A0 (it) | Cellule umane per l'elevata espressione di geni inseriti in dna ricombinanti episomiali,loro preparazione e loro impiego | |
AU6720698A (en) | Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss | |
NO993125L (no) | Steroider substituert i posisjon 11, fremgangsmåte for fremstilling av disse, deres anvendelse som medisiner samt farmasöytiske preparater inneholdende disse | |
NO965370D0 (no) | Substituerte kromanylsulfonyl(tio)ureaer, fremgangsmåter til deres fremstilling, deres anvendelse i farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene | |
NO305792B1 (no) | Substituerte benzensulfonylureaer, deres anvendelse for fremstilling av farmas°ytiske preparater og medikamenter inneholdende disse | |
NO308793B1 (no) | Ortosubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter samt legemidler inneholdende forbindelsene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |